Literature DB >> 8160807

Palmitoyl carnitine modifies sodium currents and induces transient inward current in ventricular myocytes.

J Wu1, P B Corr.   

Abstract

Long-chain acylcarnitines increase within 2 min in ischemic myocardium in vivo and induce delayed afterdepolarizations (DADs) and complex oscillations of membrane potential in vitro. This study was performed to assess the ionic currents underlying these electrophysiological alterations in isolated rabbit ventricular cells using whole cell voltage-clamp procedures. Palmitoyl carnitine (10 microM, for 6-10 min) elicited a transient inward current (Iti) in the presence of blockade of Ca2+ and K+ channels. The effect of palmitoyl carnitine was reversible after washout (n = 6). The amplitude of Iti was dependent on the amplitude of the preceding depolarization step. Palmitoyl carnitine (10 microM, for > 2 min) also induced another inward current, which was activated spontaneously at potentials between -120 and -20 mV with a linear current-voltage relationship (1.0 +/- 0.1 nA at -80 mV). This current was abolished by replacing extracellular Na+ with tetraethylammonium chloride, indicating that Na+ was the charge carrier. Inactivation of this current was slow (gamma = 885.9 +/- 89.1 ms, n = 12) or incomplete, indicating the appearance of a slow-inactivating Na+ inward current [INa(s)]. Palmitoyl carnitine always induced INa(s) before the appearance of Iti. Intracellular ethylene glycol-bis(beta-amino-ethyl ether)-N,N,N',N'-tetraacetic acid (10 mM) abolished Iti but did not suppress INa(s) (n = 4), indicating that INa(s) was not activated by intracellular Ca2+ (Cai2+). Tetrodotoxin (10 microM) also decreased the amplitude of INa(s). Thus palmitoyl carnitine induces INa(s), which likely leads to an increase in Na+ influx, thereby eliciting an increase in Cai2+ via the Na(+)-Ca2+ exchanger and leading to the development of Iti, DADs, and triggered activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8160807     DOI: 10.1152/ajpheart.1994.266.3.H1034

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  23 in total

1.  Intracellular sodium in the ischemic and reperfused heart and its role in injury.

Authors:  M Bernard; E Cabanes; D Baetz; H El Banani; C Lan; M Izquierdo; P Cozzone; D Feuvray
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.310

Review 2.  The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis.

Authors:  Charles Antzelevitch; Luiz Belardinelli
Journal:  J Cardiovasc Electrophysiol       Date:  2006-05

3.  F 15845 inhibits persistent sodium current in the heart and prevents angina in animal models.

Authors:  B Vacher; C Pignier; R Létienne; Y Verscheure; B Le Grand
Journal:  Br J Pharmacol       Date:  2009-01-07       Impact factor: 8.739

4.  Inhibition of cardiac voltage-gated sodium channels by grape polyphenols.

Authors:  C H R Wallace; I Baczkó; L Jones; M Fercho; P E Light
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

5.  Long-chain acylcarnitines activate cell stress and myokine release in C2C12 myotubes: calcium-dependent and -independent effects.

Authors:  Colin S McCoin; Trina A Knotts; Kikumi D Ono-Moore; Pieter J Oort; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-07       Impact factor: 4.310

6.  Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity.

Authors:  Joshua D Lovelock; Michelle M Monasky; Euy-Myoung Jeong; Harvey A Lardin; Hong Liu; Bindiya G Patel; Domenico M Taglieri; Lianzhi Gu; Praveen Kumar; Narayan Pokhrel; Dewan Zeng; Luiz Belardinelli; Dan Sorescu; R John Solaro; Samuel C Dudley
Journal:  Circ Res       Date:  2012-02-16       Impact factor: 17.367

7.  Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.

Authors:  L Belardinelli; J C Shryock; H Fraser
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

8.  Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts.

Authors:  Mohammed Aldakkak; Amadou K S Camara; James S Heisner; Meiying Yang; David F Stowe
Journal:  Pharmacol Res       Date:  2011-06-29       Impact factor: 7.658

9.  R 56865 exerts cardioprotective properties independent of the intracellular Na(+)-overload in the guinea pig heart.

Authors:  Matthias Hartmann; Ulrich K M Decking
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-02       Impact factor: 3.000

Review 10.  The cardiac persistent sodium current: an appealing therapeutic target?

Authors:  D A Saint
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.